Literature DB >> 22767524

SAPHO syndrome with bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer.

Katsuhiko Matsumaru1, Kazuki Nagai, Takayuki Murakami, Kazuo Andoh.   

Abstract

The authors describe a case of SAPHO syndrome with bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer. The patient had undergone transurethral resection (TUR) and was treated with BCG immunotherapy following TUR. Two years after treatment for bladder cancer, the patient had palmoplantar pustulosis, and in the past 1 month suffered from pain localised to the anterior chest wall. The bone scintigraphy showed a strong focal enrichment in the right chest wall, suggesting spondyloarthropathy rather than malignant disease. On the basis of clinical and scintigraphy findings, SAPHO syndrome was diagnosed. The patient was treated with topical therapy and non-steroidal anti-inflammatory drugs and symptoms improved. The authors suggest that SAPHO syndrome might be caused by an association with BCG immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22767524      PMCID: PMC3027574          DOI: 10.1136/bcr.12.2009.2591

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  SAPHO syndrome: a long-term follow-up study of 120 cases.

Authors:  G Hayem; A Bouchaud-Chabot; K Benali; S Roux; E Palazzo; O Silbermann-Hoffman; M F Kahn; O Meyer
Journal:  Semin Arthritis Rheum       Date:  1999-12       Impact factor: 5.532

2.  Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

Authors:  David A Zaharoff; Benjamin S Hoffman; H Brooks Hooper; Compton J Benjamin; Kiranpreet K Khurana; Kenneth W Hance; Connie J Rogers; Peter A Pinto; Jeffrey Schlom; John W Greiner
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

3.  Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome treated with a combination of isotretinoin and pamidronate.

Authors:  Hassan Galadari; Alyssa G Bishop; Suraj S Venna; Emad Sultan; Daihung Do; Ross Zeltser
Journal:  J Am Acad Dermatol       Date:  2009-07       Impact factor: 11.527

4.  Predictive value of urinary interleukin-8 cutoff point for recurrences after transurethral resection plus induction bacillus Calmette-Guérin treatment in non-muscle-invasive bladder tumors.

Authors:  Levent Sagnak; Hamit Ersoy; Ugur Ozok; Bugra Senturk; Hakan Ercil; Gul Bahar; Evrim Ozturk
Journal:  Clin Genitourin Cancer       Date:  2009-08       Impact factor: 2.872

5.  Efficacy of bacille Calmette-Guérin immunotherapy predicted by expression of antigen-presenting molecules and chemokines.

Authors:  Paula A Videira; Fernando M Calais; Manuela Correia; Dário Ligeiro; Hélio J Crespo; Fernando Calais; Hélder Trindade
Journal:  Urology       Date:  2009-05-09       Impact factor: 2.649

6.  Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.

Authors:  Jesus Fernandez-Gomez; Rosario Madero; Eduardo Solsona; Miguel Unda; Luis Martinez-Piñeiro; Marcelino Gonzalez; Jose Portillo; Antonio Ojea; Carlos Pertusa; Jesus Rodriguez-Molina; Jose Emilio Camacho; Mariano Rabadan; Ander Astobieta; Manuel Montesinos; Santiago Isorna; Pedro Muntañola; Anabel Gimeno; Miguel Blas; Jose Antonio Martinez-Piñeiro
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

Review 7.  Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature.

Authors:  Concepción Moll; M Victoria Hernández; Juan D Cañete; José A Gómez-Puerta; Alex Soriano; Antonio Collado; Raimon Sanmartí
Journal:  Semin Arthritis Rheum       Date:  2007-10-31       Impact factor: 5.532

8.  Infliximab can induce a prolonged clinical remission and a decrease in thyroid hormonal requirements in a patient with SAPHO syndrome and hypothyroidism.

Authors:  Francisca Sabugo; Claudio Liberman; Juan Pablo Niedmann; Lilian Soto; Miguel Cuchacovich
Journal:  Clin Rheumatol       Date:  2007-10-16       Impact factor: 2.980

9.  Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome.

Authors:  M Hurtado-Nedelec; S Chollet-Martin; P Nicaise-Roland; S Grootenboer-Mignot; R Ruimy; O Meyer; G Hayem
Journal:  Rheumatology (Oxford)       Date:  2008-06-17       Impact factor: 7.580

10.  Successful treatment of primary chronic osteomyelitis in SAPHO syndrome with bisphosphonates.

Authors:  Alexander Just; Sabine Adams; Thomas Brinkmeier; Vahé Barsegian; Johannes Lorenzen; Fritz Schilling; Peter Frosch
Journal:  J Dtsch Dermatol Ges       Date:  2008-02-06       Impact factor: 5.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.